GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (LTS:0DTR) » Definitions » Cyclically Adjusted Revenue per Share

Bioton (LTS:0DTR) Cyclically Adjusted Revenue per Share : zł3.93 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Bioton Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bioton's adjusted revenue per share for the three months ended in Mar. 2024 was zł0.437. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is zł3.93 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Bioton's average Cyclically Adjusted Revenue Growth Rate was -6.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -0.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bioton was -0.20% per year. The lowest was -6.30% per year. And the median was -4.25% per year.

As of today (2024-06-10), Bioton's current stock price is zł3.42829. Bioton's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was zł3.93. Bioton's Cyclically Adjusted PS Ratio of today is 0.87.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bioton was 1.43. The lowest was 0.45. And the median was 0.95.


Bioton Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bioton's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Cyclically Adjusted Revenue per Share Chart

Bioton Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.54 3.29 3.35 4.33 3.98

Bioton Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.37 4.07 3.74 3.98 3.93

Competitive Comparison of Bioton's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Bioton's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioton's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioton's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bioton's Cyclically Adjusted PS Ratio falls into.



Bioton Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bioton's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.437/149.0435*149.0435
=0.437

Current CPI (Mar. 2024) = 149.0435.

Bioton Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.931 101.180 1.371
201409 1.244 100.611 1.843
201412 1.327 100.122 1.975
201503 1.079 100.041 1.608
201506 1.138 100.448 1.689
201509 1.312 99.634 1.963
201512 0.344 99.471 0.515
201603 0.793 98.983 1.194
201606 0.902 99.552 1.350
201609 0.887 99.064 1.335
201612 0.650 100.366 0.965
201703 0.811 101.018 1.197
201706 0.999 101.180 1.472
201709 1.071 101.343 1.575
201712 1.331 102.564 1.934
201803 0.537 102.564 0.780
201806 0.990 103.378 1.427
201809 0.572 103.378 0.825
201812 0.710 103.785 1.020
201903 0.358 104.274 0.512
201906 0.842 105.983 1.184
201909 0.523 105.983 0.735
201912 0.629 107.123 0.875
202003 0.432 109.076 0.590
202006 0.585 109.402 0.797
202009 0.506 109.320 0.690
202012 1.060 109.565 1.442
202103 0.429 112.658 0.568
202106 0.425 113.960 0.556
202109 0.557 115.588 0.718
202112 0.487 119.088 0.609
202203 0.583 125.031 0.695
202206 0.560 131.705 0.634
202209 0.670 135.531 0.737
202212 0.903 139.113 0.967
202303 0.400 145.950 0.408
202306 0.571 147.009 0.579
202309 0.590 146.113 0.602
202312 0.553 147.741 0.558
202403 0.437 149.044 0.437

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bioton  (LTS:0DTR) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bioton's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.42829/3.93
=0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bioton was 1.43. The lowest was 0.45. And the median was 0.95.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bioton Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bioton's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioton (LTS:0DTR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (LTS:0DTR) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
Address
Ul. Staro?ci?ska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.

Bioton (LTS:0DTR) Headlines

No Headlines